Sitemap

Posts

• Category: Events
  • Ambit in the Media
  • Announcing the 2006 Fierce 15
• Category: women's health

Pages

• About Ambit
  • Board of Directors
  • Clinical Advisory Board - Hematology/Oncology
  • Directions to Ambit Biosciences Corporate Headquarters
  • Management Team
  • Our Strategy
  • Scientific Advisors
• Ambit Biosciences Corporation
• Ambit Biosciences Presents Data on its Targeted Cancer Therapeutic AC220 for Acute Myeloid Leukemia
• Astellas Pharma Inc
• Benefits
• Careers
• Clinical Trials
• Contact Us
• Events
• Investors
• KINOMEscan - High-Throughput Kinase Selectivity Profiling
• News
• Opportunities
• Partners
  • Strategic Partnerships
  • Teva
• Presentations
• Privacy Policy
• Product Pipeline
  • About quizartinib
  • AC220 - A Best-In-Class FLT-3 Inhibitor for AML
  • AC410
  • AC708
  • AURORA Kinase
  • BRAF Kinase
  • CEP-32496 Development
  • Scientific Publications & Presentations
• Publications
• Recruiters
• Sitemap
• Skilled. Resourceful. Validated.
• Terms of Use